Calculate your SIP ReturnsExplore

Windlas Biotech IPO Listed 17 August: Check Application Status

27 March 20236 mins read by Angel One
Windlas Biotech IPO Listed 17 August: Check Application Status
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Windlas Biotech IPO has been subscribed over 22.47 times and is finalising is allotment on 11 August. Shares of Windlas Biotech were trading at Rs. 540 each in the grey market. This would be roughly 17% higher than the issue price band of Rs. 448-460.

The company does not have any listed peers as of now. However, it competes with unlisted firms such as Innova Captab, Synokem Pharma, and Theon Pharma.

Investors who have subscribed to Windlas Biotech IPO can check its allotment status through the BSE website or Angel One app.

Check Windlas Biotech IPO Application Status on BSE

Bidders can easily check the application status for Windlas Biotech IPO on the official BSE website. Here are the steps to follow:

Step 1: Visit BSE’s official website.

Step 2: Click on the ‘Investors’ tab.

Step 3: Choose ‘equity’ as the issue type with ‘Windlas Biotech Ltd.’ as the issue name from the respective drop-down list.

Step 4: Provide the application number and the PAN details.

Step 5: Tap on ‘I’m not a robot’ and click on the ‘Submit’ button.

Thus, your application status of the Windlas Biotech IPO will appear on the screen.

Windlas Biotech IPO Application Status Check through Angel One

Apart from the BSE website, you can check the IPO application status on the Angel One app. Follow these steps:

Step 1: Log in to the Angel One mobile app.

Step 2: Look for the ‘Investment Opportunities’ option and click on it.

Step 3: Tap on the ‘IPOs and FPOs’ option.

Step 4: Click on the ‘Order Book’ option and check the status.

You will find the following 3 types of status on the app:

  • Allotted: It signifies that you have received a full allotment.
  • Partially-allotted: This shows that you have been given fewer shares than what you had applied for initially.
  • No allotment: It means you have not been allotted any number of shares.

About the Company – In Brief

Windlas Biotech Ltd. is one of the top companies dealing with pharmaceutical formulations. It provides a diverse range of CDMO services, including product development, licensing, and commercial manufacturing of generic substances.

The company has a long list of prestigious marquee customers like Cadila Healthcare, Sanofi India Ltd, Pfizer Ltd., Intas Pharmaceuticals Ltd. and more. It has highly advanced production facilities in Dehradun. These facilities have an annual capacity of 54.46 million sachets, 7,063.83 million capsules/tablets and 61.08 million bottles.

Windlas Biotech IPO opened on 4 August 2021 and closed on 6 August 2021. This company plans to use its IPO proceeds for meeting the requirements:

  • To repay or prepay external borrowings
  • For funding the general corporate expenses
  • To fund the increasing working capital requirement of Windlas Biotech
  • To buy new state-of-the-art equipment that would be required for expanding production facilities at Dehradun.

Key Dates of Windlas Biotech IPO

Take a look at some of the important dates regarding the initial public offering of Windlas Biotech:

  • Date of basis of allotment: 11 August 2021
  • Initiation of refunds: 12 August 2021
  • Credit to DEMAT account: 13 August 2021
  • Listing date: 17 August 2021

Final Takeaway

As per the NSE website, Windlas Biotech IPO has received bids for more than 13.78 crores shares against its issue size of 61.36 lakh equity shares. Shares reserved for QIBs were subscribed 24.40 times. On the other hand, shares for NIIs and RIIs were subscribed 15.73 times and 24.27 times.

To stay updated about more such IPOs, make sure to refer to Angel One blogs.


Frequently Asked Questions

  1. Where is the Windlas Biotech IPO listed?

Windlas Biotech IPO shares are listed on NSE and BSE.

  1. What is the issue size of Windlas Biotech IPO?

Rs. 401.53 crores is the issue size of Windlas Biotech IPO.

  1. Who are the book running lead managers of Windlas Biotech IPO?

DAM Capital Advisors, IIFL Securities, and SBI Capital Markets are the book running lead managers of this initial public offer.


Open Free Demat Account!

Enjoy Zero Brokerage on Equity Delivery

Join our 2 Cr+ happy customers

Enjoy Zero Brokerage on Equity Delivery
Enjoy Zero Brokerage on Equity Delivery

Get the link to download the App

Send App Link

Enjoy Zero Brokerage on
Equity Delivery